Hyunjun Park is CEO of CATALOG, a data storage and computation platform that uses little energy and delivers massive scalability. The answer is yes. The meaning of biotech has dramatically expanded ...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical -stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. The ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular ...

Evercrisp Biosciences, Inc., a portfolio company of Apple Tree Partners, entered bankruptcy within a month of a filing by ...

The Biotech industry has underperformed due to the Trump administration, RFK Jr.'s skepticism, and funding uncertainty, with major ETFs down 19-25% over six months. Some biotech companies with ...

Carvykti, a CAR-T therapy co-developed by Legend Biotech & J&J, is central to second-line multiple myeloma treatment. Both firms are actively scaling up production across bases. Carvykti sales surged ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

Avid Bioservices Inc., a Tustin-based biotech company, agreed to go private in an $850-million deal that values the company at $1.1 billion on Nov. 6. Funds managed by GHO Capital Partners LLP and ...

Forbes contributors publish independent expert analyses and insights. Jim Osman is a finance expert with over 30 years of experience. As an investor, my greatest returns have usually come from areas ...

Most biotech firms will be forced to reevaluate foreign relationships and re-route supply chains, or hope for a federal ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...